G
Ginette Schiby
Researcher at Sheba Medical Center
Publications - 63
Citations - 1595
Ginette Schiby is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 21, co-authored 60 publications receiving 1367 citations. Previous affiliations of Ginette Schiby include Boston University & Tel Aviv University.
Papers
More filters
Journal ArticleDOI
LMO2 Protein Expression Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy With and Without Rituximab
Yasodha Natkunam,Pedro Farinha,Eric D. Hsi,Christine P. Hans,Robert Tibshirani,Laurie H. Sehn,Joseph M. Connors,Dita Gratzinger,Manuel F. Rosado,Shuchun Zhao,Brad Pohlman,Nicholas Wongchaowart,Martin Bast,Abraham Avigdor,Ginette Schiby,Arnon Nagler,Gerald E. Byrne,Ronald Levy,Randy D. Gascoyne,Izidore S. Lossos +19 more
TL;DR: It is concluded that LMO2 protein expression is a prognostic marker in DLBCL patients treated with anthracycline-based regimens alone or in combination with rituximab.
Journal ArticleDOI
A Congenital Neutrophil Defect Syndrome Associated with Mutations in VPS45
Thierry Vilboux,Atar Lev,May Christine V. Malicdan,Amos J. Simon,Päivi M Järvinen,Tomas Racek,Jacek Puchałka,Raman Sood,Blake Carrington,Kevin Bishop,James C. Mullikin,Marjan Huizing,Ben Zion Garty,Eran Eyal,Baruch Wolach,Ronit Gavrieli,Amos Toren,Amos Toren,Michalle Soudack,Michalle Soudack,Osama M. Atawneh,Tatiana Babushkin,Tatiana Babushkin,Ginette Schiby,Ginette Schiby,Andrew R. Cullinane,Camila Avivi,Camila Avivi,Sylvie Polak-Charcon,Sylvie Polak-Charcon,Iris Barshack,Iris Barshack,Ninette Amariglio,Gideon Rechavi,Jutte van der Werff ten Bosch,Yair Anikster,Yair Anikster,Christoph Klein,William A. Gahl,Raz Somech,Raz Somech +40 more
TL;DR: Defective endosomal intracellular protein trafficking due to biallelic mutations in VPS45 underlies a new immunodeficiency syndrome involving impaired neutrophil function.
Journal ArticleDOI
Mutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects.
Amos J. Simon,Atar Lev,Yong Zhang,Batia Weiss,Anna Rylova,Eran Eyal,Nitzan Kol,Ortal Barel,Keren Cesarkas,Michalle Soudack,Noa Greenberg-Kushnir,Michele Rhodes,David L. Wiest,Ginette Schiby,Iris Barshack,Shulamit Katz,Elon Pras,Hana Poran,Haike Reznik-Wolf,Elena Ribakovsky,Carlos Simon,Wadi Hazou,Yechezkel Sidi,Avishay Lahad,Hagar Katzir,Shira Sagie,Haifa A. Aqeilan,Galina Glousker,Ninette Amariglio,Yehuda Tzfati,Sara Selig,Gideon Rechavi,Raz Somech +32 more
TL;DR: Two new mutations in STN1 that causes Coats plus syndrome and telomere abnormalities in human, recapitulated in a zebra fish model are identified.
Journal ArticleDOI
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
Dita Gratzinger,Shuchun Zhao,Robert Tibshirani,Eric D. Hsi,Christine P. Hans,Brad Pohlman,Martin Bast,Abraham Avigdor,Ginette Schiby,Arnon Nagler,Gerald E. Byrne,Izidore S. Lossos,Yasodha Natkunam +12 more
TL;DR: In this article, the authors have shown that increased tumor vascularity is associated with poor overall survival (P=0.047) and is independent of the international prognostic index, while high expression of vascular endothelial growth factor receptor-1 by lymphoma cells was associated with improved overall survival.
Journal ArticleDOI
Novel Proangiogenic Effect of Factor XIII Associated With Suppression of Thrombospondin 1 Expression
Rima Dardik,Arieh Solomon,Joseph Loscalzo,Regina Eskaraev,Ann Bialik,Iris Goldberg,Ginette Schiby,Aida Inbal +7 more
TL;DR: The results show that FXIIIa exhibits a novel proangiogenic activity that is associated with downregulation of TSP-1 and also involves stimulation of endothelial cell proliferation and migration and inhibition of apoptosis.